• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchBiomx
    Picture of Biomx logo

    PHGE — Biomx Share News

    $0.540.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $5.44m
    • Enterprise Value
      $22.89m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PHGE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PHGE Dividends
    • Brief: Biomx Files For Mixed Shelf Offering Of Up To $150 Million

      07/12/2023 22:13
    • Brief: Biomx Announces Positive Topline Results From Part 2 Of The Phase 1B/2A Trial Evaluating Bx004

      29/11/2023 12:58
    • Brief: BiomX Appoints Edward L. Williams to its Board of Directors

      18/10/2023 13:05
    • Brief: Biomx Announces Completion Of Patient Dosing In Part 2 Of The Phase 1B/2A Study Evaluating Bx004 For Treatment Of Chronic Pulmonary Infections In Patients With Cystic Fibrosis

      04/10/2023 11:40
    • Brief: BiomX Inc Files For Shelf Of Up To 31.8 Mln Shares Of Common Stock By Selling Stockholders

      02/06/2023 21:05
    • Brief: Biomx Reports First Quarter 2023 Financial Results And Provides Business Update

      15/05/2023 11:46
    • Brief: BiomX Announces Appointments To Board Of Directors

      12/05/2023 13:36
    • Brief: Biomx Reports Fourth Quarter And Full Year 2022 Financial Results

      29/03/2023 11:40
    • Brief: BiomX Announces $7.5 Million Private Placement

      22/02/2023 11:54
    • Brief: BiomX Announces Positive Results From Part 1 Of The Phase 1B/2A Study Evaluating BX004 For Treatment Of Chronic Pulmonary Infections In Patients With Cystic Fibrosis

      22/02/2023 11:34
    • Brief: Biomx Reports Q3 Loss of $0.23 Per Share

      09/11/2022 11:48
    • AMEX RESUMED BIOMX INC UNT

      30/09/2022 15:03
    • AMEX HALT ADDITIONAL INFORMATION LAST 0.38010

      30/09/2022 14:58
    • Brief: Biomx reports Q2 results

      10/08/2022 11:34
    • AMEX RESUMED BIOMX INC UNT

      05/08/2022 16:30
    • AMEX HALT ADDITIONAL INFORMATION LAST 1.18000

      05/08/2022 16:26
    • AMEX RESUMED BIOMX INC UNT

      05/08/2022 16:14
    • AMEX HALT ADDITIONAL INFORMATION LAST 1.78000

      05/08/2022 16:09
    • AMEX RESUMED BIOMX INC UNT

      05/08/2022 16:06
    • AMEX HALT ADDITIONAL INFORMATION LAST 1.78000

      05/08/2022 16:01
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.